Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 226184011000036113 | Madopar HBS 100/25 (benserazide 25 mg + levodopa 100 mg) modified release capsule, 100 capsules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 226185011000036112 | Madopar HBS 100/25 modified release capsule, 100 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Madopar HBS 100/25 modified release capsule, 100 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Madopar HBS 100/25 modified release capsule, 100 | Is a | levodopa 100 mg + benserazide 25 mg modified release capsule, 100 | true | Inferred relationship | Some | ||
| Madopar HBS 100/25 modified release capsule, 100 | has TPUU | Madopar HBS 100/25 modified release capsule | true | Inferred relationship | Some | 1 | |
| Madopar HBS 100/25 modified release capsule, 100 | has TP | Madopar HBS 100/25 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Madopar HBS 100/25 modified release capsule, 100, bottle | Is a | True | Madopar HBS 100/25 modified release capsule, 100 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR